APA (7th ed.) Citation

S, D., Y, C., W, C., S, D., J, Z., L, C., & CS, C. (2025). Combination immunotherapy in hepatocellular carcinoma: Synergies among immune checkpoints, TKIs, and chemotherapy. Journal of hematology & oncology, 18(1), 85. https://doi.org/10.1186/s13045-025-01739-6

Chicago Style (17th ed.) Citation

S, Dai, Chen Y, Cai W, Dong S, Zhao J, Chen L, and Cheng CS. "Combination Immunotherapy in Hepatocellular Carcinoma: Synergies Among Immune Checkpoints, TKIs, and Chemotherapy." Journal of Hematology & Oncology 18, no. 1 (2025): 85. https://doi.org/10.1186/s13045-025-01739-6.

MLA (9th ed.) Citation

S, Dai, et al. "Combination Immunotherapy in Hepatocellular Carcinoma: Synergies Among Immune Checkpoints, TKIs, and Chemotherapy." Journal of Hematology & Oncology, vol. 18, no. 1, 2025, p. 85, https://doi.org/10.1186/s13045-025-01739-6.